Speaker(s): 

Sandra Kane-Gill, PharmD, Staff Member, University of Pittsburgh - has disclosed the following: Society of Critical Care Medicine (Independent Contractor), NIDDK (Research Grant), NCCIH (Research Grant), and Jewish Healthcare Foundation (Research Grant).

Moderator(s): 

Daniel Longyhore, PharmD, EdD, BCAP, Staff Member, Geisinger - has nothing to disclose.   

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• review the contemporary definitions for drug related kidney diseases. 
• list at least three actions to achieve the goals of nephrotoxin stewardship program.  

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Daniel Longyhore, PharmD, Ed.D., BCACP; Eric Wright, PharmD, MPH; Melissa Kern, MPH; Lisabeth Karetsky, CPhT and Nichole Varela Gonzalez have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.